HealthEquity (HQY) Competitors

IQVIA (NYSE:IQV) and HealthEquity (NASDAQ:HQY) are both medical companies, but which is the superior business? We will compare the two businesses based on the strength of their dividends, media sentiment, valuation, risk, profitability, analyst recommendations, community ranking, earnings and institutional ownership.

Is IQV or HQY more profitable?

IQVIA has a net margin of 8.91% compared to HealthEquity's net margin of 8.41%. IQVIA's return on equity of 28.81% beat HealthEquity's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
IQVIA	8.91%	28.81%	7.02%
HealthEquity	8.41%	9.70%	6.08%

Does the media favor IQV or HQY?

In the previous week, IQVIA had 4 more articles in the media than HealthEquity. MarketBeat recorded 47 mentions for IQVIA and 43 mentions for HealthEquity. IQVIA's average media sentiment score of 0.87 beat HealthEquity's score of 0.70 indicating that IQVIA is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
IQVIA	26 Very Positive mention(s)	2 Positive mention(s)	8 Neutral mention(s)	7 Negative mention(s)	0 Very Negative mention(s)	Positive
HealthEquity	19 Very Positive mention(s)	3 Positive mention(s)	10 Neutral mention(s)	0 Negative mention(s)	1 Very Negative mention(s)	Positive

Which has more risk & volatility, IQV or HQY?

IQVIA has a beta of 1.46, indicating that its share price is 46% more volatile than the S&P 500. Comparatively, HealthEquity has a beta of 0.49, indicating that its share price is 51% less volatile than the S&P 500.

Which has stronger valuation & earnings, IQV or HQY?

IQVIA has higher revenue and earnings than HealthEquity. IQVIA is trading at a lower price-to-earnings ratio than HealthEquity, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
IQVIA	$15.41B	1.73	$1.37B	$7.50	20.12
HealthEquity	$1.20B	6.01	$55.71M	$1.09	76.48

Does the MarketBeat Community favor IQV or HQY?

IQVIA received 144 more outperform votes than HealthEquity when rated by MarketBeat users. However, 70.18% of users gave HealthEquity an outperform vote while only 68.30% of users gave IQVIA an outperform vote.

Company	Underperform	Outperform
IQVIA	Outperform Votes 683 68.30%	Underperform Votes 317 31.70%
HealthEquity	Outperform Votes 539 70.18%	Underperform Votes 229 29.82%

Do institutionals & insiders have more ownership in IQV or HQY?

89.6% of IQVIA shares are owned by institutional investors. Comparatively, 99.6% of HealthEquity shares are owned by institutional investors. 1.6% of IQVIA shares are owned by insiders. Comparatively, 2.2% of HealthEquity shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Do analysts rate IQV or HQY?

IQVIA currently has a consensus price target of $241.50, suggesting a potential upside of 60.02%. HealthEquity has a consensus price target of $112.58, suggesting a potential upside of 35.06%. Given IQVIA's higher probable upside, equities analysts plainly believe IQVIA is more favorable than HealthEquity.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
IQVIA	0 Sell rating(s)	5 Hold rating(s)	16 Buy rating(s)	1 Strong Buy rating(s)	2.82
HealthEquity	0 Sell rating(s)	1 Hold rating(s)	10 Buy rating(s)	1 Strong Buy rating(s)	3.00

Summary

IQVIA beats HealthEquity on 12 of the 18 factors compared between the two stocks.